1. Home
  2. SLNO vs CXT Comparison

SLNO vs CXT Comparison

Compare SLNO & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • CXT
  • Stock Information
  • Founded
  • SLNO 1999
  • CXT 1855
  • Country
  • SLNO United States
  • CXT United States
  • Employees
  • SLNO N/A
  • CXT N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CXT Office Equipment/Supplies/Services
  • Sector
  • SLNO Health Care
  • CXT Industrials
  • Exchange
  • SLNO Nasdaq
  • CXT Nasdaq
  • Market Cap
  • SLNO 3.8B
  • CXT 3.2B
  • IPO Year
  • SLNO 2014
  • CXT N/A
  • Fundamental
  • Price
  • SLNO $79.98
  • CXT $54.56
  • Analyst Decision
  • SLNO Strong Buy
  • CXT Buy
  • Analyst Count
  • SLNO 9
  • CXT 4
  • Target Price
  • SLNO $103.33
  • CXT $77.00
  • AVG Volume (30 Days)
  • SLNO 662.7K
  • CXT 468.5K
  • Earning Date
  • SLNO 08-06-2025
  • CXT 08-06-2025
  • Dividend Yield
  • SLNO N/A
  • CXT 1.25%
  • EPS Growth
  • SLNO N/A
  • CXT N/A
  • EPS
  • SLNO N/A
  • CXT 2.91
  • Revenue
  • SLNO N/A
  • CXT $1,503,500,000.00
  • Revenue This Year
  • SLNO N/A
  • CXT $8.08
  • Revenue Next Year
  • SLNO N/A
  • CXT $8.53
  • P/E Ratio
  • SLNO N/A
  • CXT $18.75
  • Revenue Growth
  • SLNO N/A
  • CXT 9.28
  • 52 Week Low
  • SLNO $36.93
  • CXT $41.54
  • 52 Week High
  • SLNO $81.54
  • CXT $67.01
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 60.77
  • CXT 53.15
  • Support Level
  • SLNO $76.14
  • CXT $53.67
  • Resistance Level
  • SLNO $81.54
  • CXT $57.60
  • Average True Range (ATR)
  • SLNO 2.49
  • CXT 1.31
  • MACD
  • SLNO 0.00
  • CXT -0.14
  • Stochastic Oscillator
  • SLNO 81.81
  • CXT 36.00

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

Share on Social Networks: